Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03634033 · ClinicalTrials.gov registry record · NA

Implementation of CAPABLE in the Michigan Medicaid Waiver

A NA study, sponsored by Grand Valley State University.

Completed
Registry status
NA
Development phase
7,777
Enrollment target

NCT03634033: Completed NA study, sponsored by Grand Valley State University.

NCT03634033 is a NA study that has completed, run by Grand Valley State University. The registered enrollment target is 7,777 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (454% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03634033, a NA study, has completed, sponsored by Grand Valley State University.

COMPLETED
Registry status
NA
Development phase
7,777 participants
Enrollment target

Study Summary

Main study: Nearly half of older adults report problems with function, which can lead to difficulty with activities of daily living and nursing home placement. Thus, there is a need to implement evidence-based models of care to improve function and those factors that support function in older adults living in the community. One such model is CAPABLE (Community Aging in Place Advancing Better Living for Elders), a person-centered, nurse and occupational therapy intervention supported by assistive devices and home modifications. The investigators build on prior work that translated CAPABLE and conducted preliminary testing of a package of implementation strategies. This R15 application will test site-level adoption and sustainability after deploying a package of implementation strategies (readiness assessment, training, facilitation, champions, coalition building, and audit and feedback). Sites will be randomized to internal facilitation alone or internal facilitation plus external facilitation. This work will impact implementation science by testing two approaches to implementation of an evidence-based intervention to improve outcomes among older adults in a Medicaid Waiver program. ADMINISTRATIVE SUPPLEMENT We extend the Parent Trial by addressing a problem found while deploying CAPABLE with beneficiaries with Alzheimer's disease (AD) or dementia. There are 39.8 million informal caregivers in the US and 16.3 million who care for someone with AD or dementia; and 1,500 of those are in the Michigan waiver. Most beneficiaries with those conditions did not accept CAPABLE as they were unable to receive instruction. Interventions that improve caregiver knowledge, confidence, and self-efficacy improve care they provide. Thus, the goal is to extend provision of CAPABLE to beneficiaries with AD or dementia via the engagement of their informal caregivers. This work is significant as there are 1,500 beneficiaries with AD or dementia in the waiver who could benefit from CAPABLE

Primary Outcome

Adoptions and sustainability of the intervention using the Stages of Implementation Completion (SIC) at a site (18). SIC is a tool that tracks achievement of key activities when implementing an evidence-based intervention. SIC has 6 stages with multiple implementation activities; each activity had an assigned numeric value and when a activity was completed, a score was assigned. The \*total\* SIC score ranges from 0-100. Stage 1 score range 0-12. Stage 2 0-16. Stage 3 0-24. Stage 4 0-16. Stage

Interventions

  • BEHAVIORAL MiCAP with IF (Main Study)
  • BEHAVIORAL MiCAP with IF and EF (Main Study)
  • BEHAVIORAL MiCAP with IF and Caregiver Engagement (Administrative Supplement)

Trial Details

FieldValue
Enrollment Target 7,777 participants
Start Date 2019-06-06
Est. Completion 2022-06-30
Phase NA
Grand Valley State University

11 total trials

What the finished NCT03634033 record still lists

NCT03634033 is an interventional study that assigns participants to a tested intervention. Its 7,777 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (454% higher).

The record links to 0 conditions, and to 3 interventions - of which MiCAP with IF (Main Study) is the first listed.

NCT03634033 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03634033 about?

NCT03634033 is a clinical study titled "Implementation of CAPABLE in the Michigan Medicaid Waiver". Main study: Nearly half of older adults report problems with function, which can lead to difficulty with activities of daily living and nursing home placement. Thus, there is a need to implement evidence-based models of care to improve function and those factors that support function in older adults...

What is the current status of trial NCT03634033?

This trial is currently completed. It is a NA study. The enrollment target is 7,777 participants. The study started on 2019-06-06. Estimated completion is 2022-06-30.

What interventions are being tested in trial NCT03634033?

The interventions under investigation include: MiCAP with IF (Main Study) (BEHAVIORAL), MiCAP with IF and EF (Main Study) (BEHAVIORAL), MiCAP with IF and Caregiver Engagement (Administrative Supplement) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03634033?

This trial is sponsored by Grand Valley State University, which has 11 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03634033's enrollment target sits among peer trials

7,777 20th of 2000 higher than 1,981 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06560398 · 7,649 participants · NA

    Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)

  • NCT03848312 · 7,600 participants · Phase 3

    Preventing Alzheimer's With Cognitive Training

  • NCT00539162 · 8,000 participants · NA

    Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

  • NCT00898638 · 8,000 participants

    Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03634033, the US trial registry maintained by the National Library of Medicine. NCT03634033 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.